The National Institute for Health Research Leadership Programme
An Evaluation of Programme Progress and Delivery
RAND Health Quarterly, 2012; 2(1):9
An Evaluation of Programme Progress and Delivery
RAND Health Quarterly, 2012; 2(1):9
RAND Health Quarterly is an online-only journal dedicated to showcasing the breadth of health research and policy analysis conducted RAND-wide.
More in this issueRAND Europe evaluated the National Institute for Health Research (NIHR) Leadership Programme in an effort to help the English Department of Health consider the extent to which the programme has helped to foster NIHR's aims, extract lessons for the future, and develop plans for the next phase of the leadership programme. Successful delivery of high-quality health research requires not only an effective research base, but also a system of leadership supporting it. However, research leaders are not often given the opportunity, nor do they have the time, to attend formal leadership or management training programmes. This is unfortunate because research has shown that leadership training can have a hugely beneficial effect on an organisation. Therefore, the evaluation has a particular interest in understanding the role of the programme as a science policy intervention and will use its expertise in science policy analysis to consider this element alongside other, more traditional, measures of evaluation.
This article presents the findings of an evaluation of the National Institute for Health Research (NIHR) Leadership Programme conducted by RAND Europe. The aim of the evaluation is to assess the extent to which the NIHR leadership programme has delivered on its three core objectives of developing individual leaders, building research team capacity and fostering leadership in the wider research community, and to look at the impact of the programme more broadly. There are four key aims to the evaluation:
The evaluation is designed to enable the English Department of Health (DH) to account for the expenditure of public funds and extract lessons for the future, as well as develop plans for the next phase of the leadership programme. The focus and methodology of the evaluation has recognised these considerations.
The NIHR Leadership Programme began delivering to researchers in January 2009. It was commissioned against a backdrop of an increasing emphasis on high-quality clinical research in the National Health Service (NHS) in the wake of Best Research for Best Health (Department of Health, 2006) and the Cooksey Report (Department of Health and Davies, 2006), and a need to deliver high-quality research within the NHS.
Delivery of this agenda requires an effective research base and system of leadership supporting it. It is widely accepted that leadership training can have a hugely beneficial effect on an organisation, no matter whether its setting is in research, the public sector or private industry. Therefore, there was a real opportunity to develop the skills and capabilities of NIHR leaders and to enable them to make a real difference to the health research environments in which they work. In this context, the programme can be thought of as an attempt at a “science policy intervention”: by investing in the leadership skills of senior researchers and future developing leaders within NIHR, there might be an improvement in the ability of the research base to deliver a strong, robust and globally competitive UK health research sector.
By focusing on three key objectives of developing individual leaders, building research team capacity and fostering leadership in the wider research community, the programme aims to help achieve change by first enabling researchers to become leaders, then supporting them in achievement of wider institutional, organisational and national goals. There are three levels of participant in the NIHR Leadership Programme:
The NIHR Leadership Programme is run by the Ashridge Business School (hereafter, Ashridge) and comprises four streams of activity:
Within these four overarching streams a range of specific activities or “interventions” are offered to participants according to their leadership group. These include:
Each programme is tailored to the leadership cohort level and the individual being supported, although there are some common features shared across all leadership groups. Senior leaders receive greater accompanying and individualised coaching support and are offered an “à la carte” approach to the programme activities, while trainee leaders follow a more structured programme centred on group learning and targeted workshops. The action learning groups are common to all levels of leader and are meant to be one of the main vehicles for participant learning during the programme, where insights and learning on the programme are converted into actionable solutions to real-world problems.
In order to evaluate the impact of the leadership programme and the extent to which it is delivering against its three objectives, we used the Kirkpatrick Model for evaluation.* The Kirkpatrick Model uses four levels of analysis to understand how the learning was received and the wider impacts that it had on the participant. For our evaluation, the model was applied to understand basic reactions to the delivery of the leadership programme; what learning and new skills were acquired during the programme; whether any behaviour change had occurred as a result of the programme; and finally, whether the leadership programme was contributing to wider outcomes and results. This framework was applied throughout the evaluation methodology, which consisted of five primary workstreams.
In any evaluation of an intervention such as the leadership programme, there will be a problem of attribution and contribution. In other words, while the leadership programme may contribute to wider outcomes, we may not be able to attribute these outcomes solely to the leadership programme. While we have taken steps to link outputs and outcomes to specific inputs and processes (through careful design of survey and interview tools, and triangulation of evidence), we recognise that there are caveats to this approach.
The leadership programme fills an important gap in academic and clinical researchers' professional development which otherwise might not be filled through their own institutions. We believe that this attests to the overall positive contribution that the programme makes to the sector, but also should be a caveat to consider when reviewing the findings. This is because individuals have little against which to compare the programme.
While all levels of leaders found the one-to-one coaching activities useful, development and senior leaders did not find other activities as useful. Overall, action learning groups were thought to be least useful by these two groups of researchers and there was variable uptake, with many not participating in them. This is surprising, given that the action learning group is a forum for bringing together the learning from all other leadership programme activities.
Trainee leaders found the action learning groups and the tailored workshops to be the most useful; however, generally they indicated a wide range of activities to be useful and programme coordination was viewed most positively by this group (as compared to some less positive views from development and senior leaders). Trainee leaders receive the most structured delivery of the activities, and we conclude that their more positive reflections on the coordination of the programme as a whole are due in part to this.
The majority of participants across all levels indicated that the programme had either a “major” or “significant” impact on their personal approach to leadership. The participants indicated that they were acquiring new skills and that these were translating, to varying extents, into changed behaviours.
Although individuals in fact may be learning and adopting new behaviours which could have wider institutional impacts, they may not always be aware of the link between the two. More than 75 percent of the respondents across all groups indicated that they are better able to manage their current institutional tasks and are more aware of the external context in which they operate. This suggests that there may be impacts on their institution due to the fact they are more aware of the context in which they work and how to manage their tasks better. However, fewer than 50 percent of development and trainee leaders thought that the programme helped them to have a major or significant impact on their own institution, and only 53 percent of senior leaders felt that they had a major or significant impact on their institution. In their comments, many respondents indicated that the impacts they felt they were having were related to being more reflective and confident as a leader, again emphasising the importance that the programme has had in fostering personal leadership development, but raising questions as to how higher-level objectives were being met.
There is weaker evidence for the impacts on research leadership, specifically within the NIHR, or more broadly within the biomedical research sector. Participants across all leadership cohorts indicated that the programme had helped to improve their performance as a leader significantly by building their confidence, but it had not been as significant in building their credibility as an intellectual leader or in helping them to influence colleagues. Insights from the in-depth interviews suggest that improvements in leadership were more about interpersonal relationships and self-awareness, rather than strengthening their ability to overcome or address research challenges: in other words, to contribute to strengthened research capacity in the NIHR.
We include a caveat in this next point, in that higher-level impacts such as improved research outputs or higher quality research are of a more long-term nature, and we would not expect to find strong evidence of these only three years into the programme. More than 60 percent of all participants, including more than 75 percent of senior leaders, reported that they believe the programme has helped them to strengthen links across research disciplines with other colleagues. However, when asked about the extent to which individuals felt the programme was enabling them to have either a personal, institutional or wider research community impact, many commented on improved self-awareness; few mentioned improved ways of doing research which otherwise might be suggested by the previous finding. This suggests that the link is not yet being made between improved leadership and research performance, and the individual's leadership role in the wider community.
The Venn diagram in Figure 1 illustrates what we believe the current balance of the NIHR Leadership Programme to be across the three objectives.
Figure 1
Integrated Leadership in the National Institute for Health Research Leadership Programme

Here, each core objective of the leadership programme is represented as a circle, with the overlaps between them reflecting how the objectives mutually support each other and how each overlap has a corresponding set of outcomes. For example, overlaps between activities which support personal and team leadership and those which aim at the objective of fostering wider NIHR leadership might be expected to reflect individual and collective contributions to the leadership of research in the NIHR. Equally, overlaps between institutional and NIHR leadership might lead to outcomes that foster connections between institutional research strategy and the wider NIHR research strategy. It should be asked whether this model of leadership is the right model for NIHR, and whether this will allow it to achieve its long-term aims of transforming biomedical and health research in the UK.
In light of the findings about the usefulness and integration of learning activities in particular, we believe that the structure of the programme for each leadership cohort needs to be critically examined in order to ensure that the activities are delivered in an integrated and coordinated fashion that clearly supports wider learning objectives. It seems that there is a particular need to address integration of programme interventions for senior leaders, as opposed to the current model where they are able to choose individual interventions in which they are interested, or for which they have time. For example, by requiring more structured participation in the programme, as opposed to the current “à la carte” model, there might be more opportunities to ensure that programme learning objectives are coordinated and achieved more readily. In addition, action learning groups, or a similar method whereby integration of programme learning occurs, should be more firmly established in the higher programme levels and steps taken to ensure that they are playing the role that they need to be in the wider programme architecture.
In order to help participants make the link between research performance and leadership, we recommend that Ashridge reconsiders the team of coaches and facilitators that deliver the programme and bring in specific experience of academic, biomedical or health research leadership expertise at key stages in participants' development over the course of the programme. This will enable participants to learn and connect leadership concepts to research challenges from people who are familiar with the research environment and contexts in which the participants function. In addition, Ashridge might consider alternate structures to the programme, where more active steps are taken to encourage both the horizontal and vertical integration of researchers and leadership levels, so that individuals learn from those facing similar disciplinary challenges but perhaps different management or institutional challenges. To this end, Ashridge might look to other leadership programme models, for example the United States National Institutes of Health (NIH), which aims to foster vertical and horizontal integration across individual research institutions through careful selection of programme participants for each leadership course.
We note in our evaluation that currently there is no formal system in place for “rolling off” the programme if one is a senior or development leader. While the trainee leader programme has a formal graduation ceremony at the end of the 18-month programme, the endpoint for the other two programmes is not as clearly defined. We found little evidence that this aspect had been appropriately addressed for these higher levels, and a more holistic consideration of the beginning, middle and end of each programme is needed.
Without a clear beginning and end for the programme, it can be difficult for participants to fully understand and appreciate the wider context in which the leadership programme is aiming to achieve change. Moreover, it can be difficult to discuss the continuity, future skills development and continued learning needed to sustain a leadership community. It is difficult to see how a wider leadership community is being established without this aspect being addressed, and in fact many participants felt that this was actively discouraged. Therefore, there is a missed opportunity in developing a wider community of leaders within the NIHR. This would contribute to individuals taking more responsibility for their position in the wider research community, and would be likely to contribute to better achievement of the third objective of the programme. In addition, it would help to ensure that the objectives of the programme as a whole are met and are contributing to wider NIHR objectives.
We believe that this is an issue for the DH and senior leadership of NIHR to consider and work through with Ashridge. There is an opportunity to understand better how an NIHR theory of change in the biomedical and health research sector can be achieved through delivery of the leadership programme.
This would not only require continued and ongoing investment in the leadership programme, but concentrated efforts to embed leadership development and awareness throughout the biomedical and health research landscape. This might be achieved, for example, by requiring all grant applications to have a “leadership and development” section. It might involve more concentrated efforts at enabling a group of NIHR leaders to work within their research communities to lead on particular research issues, public health challenges or shared academic concerns, such as the opportunities and challenges provided by the Research Excellence Framework. Ashridge could facilitate and support these community-driven initiatives through the leadership programme and provide individuals with the leadership guidance and skills to do this.
On the basis of all the above, we conclude that Ashridge has built up a suitable foundational knowledge of the NIHR and has an awareness of the individual leadership needs of researchers. After three years, we believe that it has achieved an acceptable level of success in delivering strongly on the first objective, and is beginning to deliver on the second objective. The third objective will require more time to be met, but could be more readily achieved through consideration of our recommendations.
Department of Health (Research and Development Directorate), Best Research for Best Health: A New National Health Research Strategy, 2006. As of October 12, 2011:
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4127127
Department of Health and S. C. Davies, Sir David Cooksey's Review of UK Health Research, 2006. As of October 12, 2011:
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_062915
* See http://www.kirkpatrickpartners.com/OurPhilosophy/tabid/66/Default.aspx.
RAND Health Quarterly is produced by the RAND Corporation. ISSN 2162-8254.
Explore RAND Health Quarterly articles on PubMed